CO117 Risk of Cardiovascular Events, Cancer, and All-Cause Mortality in JAK Inhibitors Compared to TNF Inhibitors: Analysis of a Large Real-World Claims Database
Abstract
Authors
R Argoubi G Nowacki M Furegato S Purinton P Medina